Transferrin saturation and hospital length of stay and mortality in medicare beneficiaries

Journal of the American Geriatrics Society

Volumn 61, Issue 1, 2013, Pages 132-136

  Mainous, Arch G ^a   Diaz, Vanessa A ^a   Knoll, Michele E ^a   Hulihan, Mary M ^b   Grant, Althea M ^b   Wright, Robert U ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b NATIONAL CENTER ON BIRTH DEFECTS AND DEVELOPMENTAL DISABILITIES   (United States)

Author keywords

Medicare; mortality; National Health and Nutrition Examination Survey; transferrin saturation

Indexed keywords

TRANSFERRIN;

ACUTE HEART INFARCTION; AGED; CLINICAL EXAMINATION; FEMALE; HEART FAILURE; HUMAN; IRON BINDING CAPACITY; ISCHEMIC HEART DISEASE; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEDICARE; MORTALITY; OUTCOME ASSESSMENT; PNEUMONIA; PROTEIN BLOOD LEVEL; PROTEIN METABOLISM; REVIEW; RISK ASSESSMENT;

AGED; CHRONIC DISEASE; FEMALE; FOLLOW-UP STUDIES; HEMOCHROMATOSIS; HOSPITAL MORTALITY; HOSPITALS; HUMANS; LENGTH OF STAY; MALE; MEDICARE; NUTRITION SURVEYS; ODDS RATIO; PROSPECTIVE STUDIES; TRANSFERRIN; UNITED STATES;

EID: 84872270502     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/jgs.12044     Document Type: Review

References (32)

1. Edwards CQ, Kushner JP,. Screening for hemochromatosis. N Engl J Med 1993; 328: 1616-1620.
2. Pippard MJ,. Detection of iron overload. Lancet 1997; 349: 73-74.
3. Schmitt B, Golub RM, Green R,. Screening primary care patients for hereditary hemochromatosis with transferrin saturation and serum ferritin level: Systematic review for the American College of Physicians. Ann Intern Med 2005; 143: 522-536.
4. Qaseem A, Aronson M, Fitterman N, et al. Screening for hereditary hemochromatosis: A clinical practice guideline from the American College of Physicians. Ann Intern Med 2005; 143: 517-521.
5. Iron Disorders Institute. Hemochromatosis diagnosis algorithm: Clinical evaluation and management protocol [on-line]. Available at http://www. irondisorders.org/Websites/idi/files/Content/854256/HHC%20ALL2011.pdf Accessed October 29, 2012.
6. Mainous AG III, Gill JM, Carek PJ,. Elevated transferrin saturation and mortality. Ann Fam Med 2004; 2: 133-138.
7. Mainous AG III, Wells BJ, Carek PJ, et al. The mortality risk of elevated serum transferrin saturation and consumption of dietary iron. Ann Fam Med 2004; 2: 139-144.
8. Mainous AG III, Gill JM, Everett CJ,. Transferrin saturation, dietary iron intake, and risk of cancer. Ann Fam Med 2005; 3: 131-137.
9. Ellervik C, Tybjaerg-Hansen A, Nordestgaard BG,. Total mortality by transferrin saturation levels: Two general population studies and a meta analysis. Clin Chem 2011; 57: 459-466.
10. Sempos CT, Looker AC, Gillum RF, et al. Body iron stores and risk of coronary disease. N Engl J Med 1994; 330: 1119-1124.
11. Menke A, Muntner P, Fernandez-Real JM, et al. The association of biomarkers of iron status with mortality in US adults. Nutr Metab Cardiovasc Dis 2012; 22: 734-740.
12. Looker AC, Johnson CL,. Prevalence of elevated serum transferrin saturation in adults in the United States. Ann Intern Med 1998; 129: 940-945.
13. National Digestive Diseases Information Clearinghouse (NDDIC): USDHHS. Hemochromatosis [on-line]. Available at http://digestive.niddk.nih.gov/ ddiseases/pubs/hemochromatosis/ Accessed October 29, 2011.
14. Centers for Disease Control and Prevention. Hemochromatosis (iron storage disease): Training & education-treatment and management [on-line]. Available at http://www.cdc.gov/ncbddd/hemochromatosis/training/treatment/index. html Accessed October 29, 2012.
15. Centers for Disease Control and Prevention. Surveillance for morbidity and mortality among older adults-United States, 1995-1996 [on-line]. Available at http://www.cdc.gov/mmwr/preview/mmwrhtml/ss4808a2.htm Accessed October 29, 2012.
16. National Center for Health Statistics. Data access: NCHS Data linked to CMS Medicare enrollment and claims files [on-line]. Available at http://www.cdc.gov/nchs/data-access/data-linkage/cms-medicare.htm Accessed October 29, 2012.
17. NHANES I Epidemiologic Follow-up Survey (NHEFS) calibration sample for NDI matching methodology. National Center for Health Statistics [on-line]. Available at http://www.cdc.gov/nchs/data/datalinkage/mort-calibration-study.pdf Accessed October 29, 2012.
18. Schrier SL., Causes and diagnosis of anemia due to iron deficiency in up to date 19.2. Section Editor Mentzer WC, Deputy Editor Stephen Landaw A. May 2011 [on-line]. Available at http://www.uptodate.com/contents/causes-and- diagnosis-of-anemia-due-to-iron-deficiency?source=preview&anchor= H13&selectedTitle=1~150#H13 Accessed October 29, 2012.
19. Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chronic Dis 1987; 40: 373-383.
20. American Diabetes Association (ADA). Summary of revisions for the 2010 clinical practice recommendations. Diabetes Care 2010; 33 (Suppl): S3.
21. Clark JM, Brancati FL, Diehl AM,. The prevalence and etiology of elevated aminotransferase levels in the United States. Am J Gastroenterol 2003; 98: 960-967.
22. Molitch ME, DeFronzo RA, Franz MJ, et al. American Diabetes Association. Nephropathy in diabetes. Diabetes Care 2004; 27 (Suppl 1): S79-S83.
23. Centers for Medicare and Medicaid. Medicare provider analysis and review (MEDPAR) file [on-line]. Available at https://www.cms.gov/IdentifiableDataFiles/ 05-MedicareProviderAnalysisandReviewFile.asp Accessed October 29, 2012.
24. Graubard BI, Korn EL,. Predictive margins with survey data. Biometrics 1999; 55: 652-659.
25. Brissot P, Ropert M, Le Lan C, et al. Non-transferrin bound iron: A key role in iron overload and iron toxicity. Biochim Biophys Acta 2012; 1820: 403-410.
26. Gaenzer H, Marschang P, Sturm W, et al. Iron stores and impaired endothelial function in patients with hereditary hemochromatosis. J Am Coll Cardiol 2002; 40: 2189-2194.
27. Ellervik C, Mandrup-Poulsen T, Andersen HU, et al. Elevated transferrin saturation and risk of diabetes: Three population-based studies. Diabetes Care 2011; 34: 2256-2258.
28. Agarwal R,. Nonhematological benefits of iron. Am J Nephrol 2007; 27: 565-571.
29. Anemia Fact Sheet. Iron Disorders Institute [on-line]. Available at http://www.irondisorders.org/Websites/idi/files/Content/854256/FActsAnemia.pdf Accessed October 29, 2012.
30. Mukhopadhyay D, Mohanaruban K,. Iron deficiency anaemia in older people: Investigation, management, and treatment. Age Ageing 2002; 31: 87-91.
31. Mainous AG III, Diaz VA, Matheson EM, et al. Trends in hospitalizations with antibiotic-resistant infections: U.S., 1997-2006. Public Health Rep 2011; 126: 354-360.
32. Mainous AG III, Diaz VA, Everett CJ, et al. Impact of insurance and hospital ownership on hospital length of stay among patients with ambulatory care sensitive conditions. Ann Fam Med 2011; 9: 489-495.